Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review

Critical Reviews in Oncology/Hematology

Volumn 73, Issue 2, 2010, Pages 111-125

  Orlandi, Ester ^a   Palazzi, Mauro ^a   Pignoli, Emanuele ^a   Fallai, Carlo ^a   Giostra, Antonella ^a   Olmi, Patrizia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Accelerated fractionation; Head and neck cancer; Radiobiological efficacy; SIB IMRT technique

Indexed keywords

PLATINUM COMPLEX;

ACUTE TOXICITY; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; DYSPHAGIA; EXPERIENCE; FALSE ANEURYSM; HEAD AND NECK CANCER; HEARING LOSS; HUMAN; HYPOPHARYNX CANCER; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; MOUTH CANCER; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; OROPHARYNX CANCER; OVERALL SURVIVAL; PHARYNGITIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; RADIOSENSITIZATION; REVIEW; TISSUE NECROSIS; TONSIL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; CARCINOMA; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEAD AND NECK NEOPLASMS; HUMANS; RADIOBIOLOGY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RELATIVE BIOLOGICAL EFFECTIVENESS; TIME FACTORS;

EID: 73749085802     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2009.03.003     Document Type: Review

References (91)

1. Xia P., Fu K.K., Wong G.W., Akazawa C., and Verhey L.J. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48 (2000) 329-337
2. Hunt M.A., Zelefsky M.J., Wolden S., et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 49 (2001) 623-632
3. Kam M.K.M., Chau R.M.C., Suen J., Choi P.H.K., and Teo P.M.L. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 56 (2003) 145-157
4. Cozzi L., Fogliata A., Bolsi A., Nicolini G., and Bernier J. Three-dimensional conformal vs intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters. Int J Radiat Oncol Biol Phys 58 (2004) 617-624
5. Nutting C.M., Convery D.J., Cosgrove V.P., et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 60 (2001) 173-180
6. Dogan N., Leybovich L.B., King S., Sethi A., and Emami B. Improvement of treatment plans developed with intensity-modulated radiation therapy for concave-shaped head and neck tumors. Radiology 223 (2002) 57-64
7. Clark C.H., Bidmead A.M., Mubata C.D., Harrington K.J., and Nutting C.M. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol 70 (2004) 189-198
8. Mock U., George D., Bogner J., Auberger T., and Potter R. Treatment planning comparison of conventional, 3D conformal and intensiry-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys 58 (2004) 147-154
9. Palazzi M., Orlandi E., Pignoli E., et al. Target coverage in head and neck cancer treated with intensity modulated radiotherapy: a comparison between conventional and conformal techniques. Tumori 92 (2006) 503-510
10. Adams E.J., Nutting C.M., Convery D.J., et al. Potential role of intensity-modulated radiotherapy in the treatment of tumors of the maxillary sinus. Int J Radiat Oncol Biol Phys 51 (2001) 579-588
11. Chao K.S.C., Ozygit G., Tran B.N., Cengiz M., Dempsey J.F., and Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
12. RTOG protocol 0022. Phase I/II study of conformal and intensity modulated irradiation for oropharyngeal cancer. http://www.rtog.org.members/protocols/h0022/h0022.pdf.
13. Dogan N., King S., Emami B., et al. Assessment of different IMRT boost delivery methods on target coverage and normal tissue sparing. Int J Radiat Oncol Biol Phys 57 (2003) 1480-1491
14. Fogliata A., Bolsi A., Cozzi L., and Bernier J. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. Radiother Oncol 69 (2003) 267-275
15. Mohan R., Wu Q., Manning M., and Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 46 (2000) 619-630
16. (on behalf of the GORTEC), Bourhis J., Sire C., Lapeyre M., et al. Accelerated radiotherapy and/or concomitant chemotherapy in locally advanced head and neck SCC: results of a GORTEC randomized trial. Radiother Oncol 88 2 (2008) S121
17. Butler E.B., Teh B.S., Grant III W.H., et al. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule foe the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 45 (1999) 21-32
18. Chao K.S.C., Ozyigit G., Tran B.N., Cengiz M., Dempsey J.F., and Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck caner. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
19. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
20. Mark J.E., Bedwinek J.M., Lee F., Purdy J.A., and Perez C.A. Dose-response analysis for nasopharyngeal carcinoma: an historical perspective. Cancer 50 (1982) 1042-1050
21. Teo P.M., Leung S.F., Tung S.Y., et al. Dose-response relationship of nasopharyngeal carcinoma above conventional tumorocidal level: a study by the Hong Kong group (HKNPCSG). Radiother Oncol 79 (2006) 27-33
22. Joiner M.C. Hyperfractionation and accelerated radiotherapy. In: Steel G.G. (Ed). Basic clinical radiobiology (1997), Arnold, London 123-131
23. Yang Y., and Xing L. Optimization of radiotherapy dose-time fractionation with consideration of tumor specific biology. Med Phys 32 (2005) 3666-3677
24. Fowler J.F. Biological factors influencing optimum fractionation in radiation therapy. Acta Oncol 40 (2001) 712-717
25. Maciejewski B., Withers H.R., Taylor J.M.G., and Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose response and repopulation. Int J Radiat Oncol Biol Phys 16 (1989) 831-843
26. Withers H.R., Taylor J.M.G., and Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146
27. Roberts S.A., and Hendry J.H. The delay before onset of accelerated tumor cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumor control data. Radiother Oncol 29 (1993) 69-74
28. Roberts S.A., Hendry J.H., Brewster A.E., and Slevin N.J. The influence of radiotherapy treatment on the control of laryngeal cancer: a direct analysis of data of two British Institute of Radiology trials to calculate the lag period and the time factor. Br J Radiol 67 (1994) 790-794
29. Taylor J.M.G., and Withers H.R. Dose-time factors in head and neck data. Radiother Oncol 25 (1992) 313-315
30. Withers H.R., Peters L.J., Taylor J.M.G., et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiot Oncol Biol Phys 33 (1995) 549-562
31. Bentzen S.M., and Thames H.D. Clinical evidence for tumor clonogen regeneration: interpretations of data. Radiother Oncol 22 (1991) 161-166
32. Tarnawski R., Fowler J., Skladowski K., et al. How fast is repopulation of tumor cells during the treatment gap?. J Radiot Oncol Biol Phys 54 (2002) 229-236
33. Nguyen L.N., and Ang K.K. Radiotherapy for cancer of the head and neck: altered fractionation regimes. Lancet Oncol 3 (2002) 693-701
34. Fowler J. Dose-responses curves for organ function in cell survival. Br J Radiol 56 (1983) 497-500
35. Dorr W., Hamilton C.S., Boyd D., Reed B., and Denham J.W. Radiation induced changes in human oral mucosa. Int J Radiat Oncol Biol Phys 52 (2002) 911-917
36. Fowler J.F., Harari P.M., Leborgne F., and Leborgne J.H. Acute radiation reaction in oral mucosa and pharyngeal mucosa: tolerable level in altered fractionation schedules. Radiother Oncol 69 (2003) 161-168
37. Trans Tasman Radiation Oncology Group (TROG), Denham J.W., Walker Q.J., Lamb D.S., Hamilton C.S., O'Brien P.C., and Spry N.A. Mucosal regeneration during radiotherapy. Radiother Oncol 41 (1996) 109-118
38. Stewart F.A., and van der Kogel A.J. Proliferative and cellular organization of normal tissues. In: Steel G.G. (Ed). Basic clinical radiobiology (1997), Arnold, London 24-29
39. Hornsey S., Myers R., Coultas P.G., Rogers M.A., and White A. Turnover of proliferative cells in the spinal cord after X irradiation and its relation to time-dependent repair of radiation damage. Br J Radiol 54 (1981) 1081-1085
40. Dorr W., and Hendry J.H. Consequential late effects in normal tissues. Radiother Oncol 61 (2001) 223-231
41. Robertson A.G., Robertson C., Boyle P., Sysmonds R.P., and Wheldon T.E. The effect of differing radiotherapeutic schedules on the glottic carcinoma of the larynx. Eur J Cancer 29 (1993) 501-510
42. Joiner M.C., and van der Kogel A.J. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel G.G. (Ed). Basic clinical radiobiology (1997), Arnold, London 107-122
43. Le Q.T., Fu K.K., Kroll S., et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 39 (1997) 115-126
44. Fowler J.F. Fractionation and glottic carcinoma. Int J Radiat Oncol Biol Phys 39 (1997) 1-2
45. Denham J.W., Hamilton C.S., Simpson S.A., et al. Acute reaction parameters for human oropharyngeal mucosa. Radiother Oncol 35 (1995) 129-137
46. Thames H.D., Bentzen S.M., Turesson I., Overgaard M., and Van den Bogaert W. Fractionation parameters for human tissues and tumors. Int J Radiat Oncol Biol Phys 56 (1989) 701-710
47. Chougule A., and Supe J. Linear quadratic model-estimation of alpha/beta ratio for mucosal reaction. Strahlenther Onkol 69 (1993) 427-430
48. Withers H.R., Peters L.J., Taylor J.M., et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys 33 (1995) 563-568
49. Dische S., Martin W.M., and Anderson P. Radiation myelopathy in patients treated for carcinoma of bronchus using a six fraction regime of radiotherapy. Br J Radiol 54 (1981) 29-35
50. The Medical Research Council Lung Cancer Working Party, Macbeth F.R., Wheldon T.E., Girlin D.J., et al. Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. Clin Oncol 8 (1996) 176-181
51. McCunnuf A.J., and Liang M.J. Radiation tolerance of the cervical spinal cord. Int J Radiat Oncol Biol Phys 16 (1989) 675-678
52. Lee A.W., Foo W., Chappell R., et al. Effect of time, dose and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 40 (1998) 35-42
53. Parsons J.T., Bova F.J., Fitzgerald C.R., Mendenhall W.M., and Million R.R. Radiation optic neuropathy after megavoltage external beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30 (1994) 755-763
54. Anteunis L.J., Wanders S.L., Hendriks J.J., Langendijk J.A., Manni J.J., and De Jong J.M.A. A prospective longitudinal study on radiation-induced hearing loss. Am J Surg 168 (1994) 408-411
55. Deore S.M., Supe S.J., Sharma V., and Dinshaw K.A. Importance of dose per fraction and estimation of an alpha/beta value for the late complications of the vocal cord. Strahlenther Onkol 167 (1991) 608-611
56. Jackson S.M., Weir L.M., Hay J.H., Tsang V.H., and Durham J.S. Randomized trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43 (1997) 39-46
57. Skladowski K., Maciejewski J., Golen M., Pilecki B., Przorek W., and Tarnawski R. Randomized clinical trial on 7-day continuous accelerated irradiation (CAIR) of head and neck cancer: report on 3-years tumor control and normal tissue toxicity. Radiother Oncol 55 (2000) 101-110
58. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous cell carcinoma of the head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
59. Dische S., Sauders M., Barret A., Harvey A., Gibson D., and Parmar M. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44 (1997) 123-136
60. A trans-Tasman radiation Oncology Group Study, Poulsen M.G., Denham J.W., and Peters L.J. A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous cell carcinoma of the head and neck. Radiother Oncol 60 (2001) 113-122
61. Horiot J.C., Bontemps P., Van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 44 (1997) 111-121
62. Olmi P., Crispino S., Fallai C., et al. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. Concomitant radiotherapy and chemotherapy-a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 78-92
63. Bourhis J., Lapeyre M., and Tortochaux J. Very accelerated versus conventional radiotherapy in HNSCC: results of the GORTEC 94-02 randomized trial. Int J Radiat Biol Phys 48 (2001) S111
64. Dobrowsky W., and Naudé J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol 57 (2000) 119-124
65. Palcic B., and Skarsgard L. Reduced oxygen enhancement ratio at low doses of ionizing radiation. Radiat Res 100 (1984) 328-339
66. Ang K.K., Peters L.J., Weber R.S., et al. Concomitant boost radiotherapy schedule in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19 (1990) 1339-1345
67. Gwozdz J.T., Morrison W.H., Garden A.S., Weber R.S., Peter L.J., and Ang K.K. Concomitant boost radiotherapy for squamous cell carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys 39 (1997) 127-135 fin qui a posto
68. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368 (2006) 843-854
69. Lee A.W., Sze W.M., Yau T.K., Yeung R.M., Chappell R., and Fowler J.F. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. Radiother Oncol 58 (2001) 121-130
70. Wang C.C. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techiques and results. Cancer 63 (1989) 2461-2467
71. Teo P.M., Leung S.F., Chan A.T., et al. Final report of a randomized trial on altered-fractionad radiotherapy in nasopharyngeal carcinoma prematurely terminated by sigificant increase in neurologic complications. Int J Radiat Oncol Biol Phys 48 (2000) 1311-1322
72. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
73. Kam M., Teo P.M., Chau R.M., et al. Treatment of nasopharyngeal carcinoma with intensity modulated radiotherapy: the Honk Kong experience. Int J Radiat Oncol Biol Phys 60 (2004) 1440-1450
74. Kwong D.L., Sham J.S., Leung L.H., et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 64 (2006) 374-381
75. Wolden S.L., Chen W.C., Pfister D.G., Kraus D.H., Berry S.L., and Zelefsky M.J. Intensity modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62
76. Lee S.W., Back G.M., Yi B.Y., et al. Preliminary results of a Phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 152-160
77. Wu S., Xie C., Jin X., and Zhang P. Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer: a local center's experience. Int J Radiat Oncol Biol Phys 66 (2006) S40-S46
78. De Arruda F.F., Puri D.R., Zhung J., et al. Intensity modulated radiation therapy for the treatment of oropharyngeal carcinoma; the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64 (2006) 363-373
79. Lauve A., Morris M., Schmidt Ullrich R.S., et al. Simultaneous integrated boost intensity modulated radiotherapyfor locally advances head and neck squamous cell carcinomas, II-clinicla results. Int J Radiat Oncol Biol Phys 60 (2004) 374-387
80. Yao M., Dornfeld K.J., Buatti J.M., et al. Intensity-modulated radiation treatment for head and neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 63 (2005) 410-421
81. Studer G., Huguenin P.U., Davis J.B., Lutolf U.M., and Glanzmann C. IMRT using simultaneously integrated boost (SIB) in head and neck patients. Radiat Oncol 31 (2006) 1-7
82. Schwartz M., Vuong T., Ballivy O., Parker W., and Patrocinio H. Accelerated radiotherapy with simultaneous integrated boost fractionation and intensity-modulated radiotherapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 136 (2007) 549-555
83. Guerrero Urbano T., Clark C.H., Hansen V.N., et al. A Phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiot Oncol 85 (2007) 36-41
84. Lee N.Y., O'Meara W., Chan K., et al. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 69 (2007) 459-468
85. RT0G 0225. A Phase II study of intensity modulated radiation therapy (IMRT) +/- chemotherapy for nasopharyngeal cancer. http://www.rtog.org.members/protocols/0225/0225.pdf.
86. Thames H.D., Withers H.R., Peter L.J., and Fletcher G.H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 8 (1982) 219-226
87. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349 (2003) 2091-2098
88. Lee N.Y., De Arruda F.F., Puri D.R., et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 966-974
89. Sanguineti G., Endres E.J., Gunn B.G., and Parker B. Is there a "mucosa-sparing" benefit of IMRT for head and neck cancer?. Int J Radiat Oncol Biol Phys 66 (2006) 931-938
90. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
91. Fowler J.F., Tomè W.A., Fenwick J.D., and Mehta M.P. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60 (2004) 1241-1256